100 likes | 256 Views
Media Briefing. Saturday, April 16th 10:00 am – Media briefing begins Announcement of poster winners and a short presentation from some of the winning authors Introduction of Yehuda Handelsman, MD, FACP, FACE, FNLA as the new President of AACE
E N D
Media Briefing Saturday, April 16th 10:00 am – Media briefing begins Announcement of poster winners and a short presentation from some of the winning authors Introduction of Yehuda Handelsman, MD, FACP, FACE, FNLA as the new President of AACE 10:25 am – Floor opens to questions from the media 10:30 am – Media Briefing adjourns
AACE 2011 OMENTECTOMY ADDED TO ROUX-EN-Y GASTRIC BYPASS IMPROVES GLUCOSE AND ADIPOKINES AT 90 DAYS:A RANDOMIZED, CONTROLLED TRIAL TH Dillard1, JQ Purnell1, MD Smith2, J Laut2, W Raum2, D Hong3, E Patterson2 Department of Medicine, Division of Endocrinology, Diabetes, and Clinical Nutrition. Oregon Health & Science University, Portland, OR Department of Surgery, Legacy Good Samaritan Hospital, Portland, OR; Department of Surgery, St. Joseph's Hospital, McMaster University, Hamilton, Ontario, Canada
Coagulation abnormalities in Diabetes Mellitus type 2 and microvascular complications Ritu Madan MD
Study design • Single center case control study between 2006-2008 • 60 patients with diabetes, 20 with and 40 without complications (nephropathy, retinopathy, neuropathy) • Equal number of males and females • Evaluation of major coagulation parameters
Conclusions • Microvascular complications of Type-2 Diabetes are associated with changes in coagulation parameters. • Differences in coagulation parameters were seen in diabetics with complications of nephropathy and retinopathy compared to diabetics without these complications. • The magnitude of the coagulation abnormalities is unlikely to cause symptomatic thrombotic events and hence may be clinically silent.